The global CAR-T Therapy market was valued at US$ 3.8 billion in 2024 and is projected to reach US$ 8.5 billion by 2030, at a CAGR of 14.4%.
The United States CAR-T Therapy market was valued at US$ 1.5 billion in 2024 and is projected to reach US$ 3.2 billion by 2030, at a CAGR of 13.5%.
Advanced immunotherapy using genetically modified T cells to target specific cancer cells, including manufacturing processes and delivery systems under strict regulatory control.
Oncology centers: 72% adoption. Success rate up 35%. R&D investment: 28% revenue. Manufacturing efficiency improved 40%. Leaders hold 80% market share.
Report Overview
This report provides a deep insight into the global CAR-T Cellular Immunotherapy Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CAR-T Cellular Immunotherapy Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CAR-T Cellular Immunotherapy Drug market in any manner.
Global CAR-T Cellular Immunotherapy Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma
Market Segmentation (by Type)
CD19-Targeted
BCMA-Targeted
Market Segmentation (by Application)
Multiple Myeloma
Non-Hodgkin lymphoma
Leukemia
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR-T Cellular Immunotherapy Drug Market
Overview of the regional outlook of the CAR-T Cellular Immunotherapy Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of CAR-T Cellular Immunotherapy Drug
1.2 Key Market Segments
1.2.1 CAR-T Cellular Immunotherapy Drug Segment by Type
1.2.2 CAR-T Cellular Immunotherapy Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR-T Cellular Immunotherapy Drug Market Overview
2.1 Global Market Overview
2.1.1 Global CAR-T Cellular Immunotherapy Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global CAR-T Cellular Immunotherapy Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR-T Cellular Immunotherapy Drug Market Competitive Landscape
3.1 Global CAR-T Cellular Immunotherapy Drug Sales by Manufacturers (2019-2025)
3.2 Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 CAR-T Cellular Immunotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CAR-T Cellular Immunotherapy Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers CAR-T Cellular Immunotherapy Drug Sales Sites, Area Served, Product Type
3.6 CAR-T Cellular Immunotherapy Drug Market Competitive Situation and Trends
3.6.1 CAR-T Cellular Immunotherapy Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest CAR-T Cellular Immunotherapy Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CAR-T Cellular Immunotherapy Drug Industry Chain Analysis
4.1 CAR-T Cellular Immunotherapy Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of CAR-T Cellular Immunotherapy Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CAR-T Cellular Immunotherapy Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Type (2019-2025)
6.3 Global CAR-T Cellular Immunotherapy Drug Market Size Market Share by Type (2019-2025)
6.4 Global CAR-T Cellular Immunotherapy Drug Price by Type (2019-2025)
7 CAR-T Cellular Immunotherapy Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR-T Cellular Immunotherapy Drug Market Sales by Application (2019-2025)
7.3 Global CAR-T Cellular Immunotherapy Drug Market Size (M USD) by Application (2019-2025)
7.4 Global CAR-T Cellular Immunotherapy Drug Sales Growth Rate by Application (2019-2025)
8 CAR-T Cellular Immunotherapy Drug Market Segmentation by Region
8.1 Global CAR-T Cellular Immunotherapy Drug Sales by Region
8.1.1 Global CAR-T Cellular Immunotherapy Drug Sales by Region
8.1.2 Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Region
8.2 North America
8.2.1 North America CAR-T Cellular Immunotherapy Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CAR-T Cellular Immunotherapy Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CAR-T Cellular Immunotherapy Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CAR-T Cellular Immunotherapy Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CAR-T Cellular Immunotherapy Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis AG
9.1.1 Novartis AG CAR-T Cellular Immunotherapy Drug Basic Information
9.1.2 Novartis AG CAR-T Cellular Immunotherapy Drug Product Overview
9.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Product Market Performance
9.1.4 Novartis AG Business Overview
9.1.5 Novartis AG CAR-T Cellular Immunotherapy Drug SWOT Analysis
9.1.6 Novartis AG Recent Developments
9.2 Kite Pharma
9.2.1 Kite Pharma CAR-T Cellular Immunotherapy Drug Basic Information
9.2.2 Kite Pharma CAR-T Cellular Immunotherapy Drug Product Overview
9.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Product Market Performance
9.2.4 Kite Pharma Business Overview
9.2.5 Kite Pharma CAR-T Cellular Immunotherapy Drug SWOT Analysis
9.2.6 Kite Pharma Recent Developments
9.3 Bristol Myers Squibb
9.3.1 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Basic Information
9.3.2 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product Overview
9.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product Market Performance
9.3.4 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug SWOT Analysis
9.3.5 Bristol Myers Squibb Business Overview
9.3.6 Bristol Myers Squibb Recent Developments
9.4 Fosun Pharma
9.4.1 Fosun Pharma CAR-T Cellular Immunotherapy Drug Basic Information
9.4.2 Fosun Pharma CAR-T Cellular Immunotherapy Drug Product Overview
9.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Product Market Performance
9.4.4 Fosun Pharma Business Overview
9.4.5 Fosun Pharma Recent Developments
10 CAR-T Cellular Immunotherapy Drug Market Forecast by Region
10.1 Global CAR-T Cellular Immunotherapy Drug Market Size Forecast
10.2 Global CAR-T Cellular Immunotherapy Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CAR-T Cellular Immunotherapy Drug Market Size Forecast by Country
10.2.3 Asia Pacific CAR-T Cellular Immunotherapy Drug Market Size Forecast by Region
10.2.4 South America CAR-T Cellular Immunotherapy Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CAR-T Cellular Immunotherapy Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global CAR-T Cellular Immunotherapy Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of CAR-T Cellular Immunotherapy Drug by Type (2025-2030)
11.1.2 Global CAR-T Cellular Immunotherapy Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of CAR-T Cellular Immunotherapy Drug by Type (2025-2030)
11.2 Global CAR-T Cellular Immunotherapy Drug Market Forecast by Application (2025-2030)
11.2.1 Global CAR-T Cellular Immunotherapy Drug Sales (K Units) Forecast by Application
11.2.2 Global CAR-T Cellular Immunotherapy Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CAR-T Cellular Immunotherapy Drug Market Size Comparison by Region (M USD)
Table 5. Global CAR-T Cellular Immunotherapy Drug Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global CAR-T Cellular Immunotherapy Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2022)
Table 10. Global Market CAR-T Cellular Immunotherapy Drug Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers CAR-T Cellular Immunotherapy Drug Sales Sites and Area Served
Table 12. Manufacturers CAR-T Cellular Immunotherapy Drug Product Type
Table 13. Global CAR-T Cellular Immunotherapy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CAR-T Cellular Immunotherapy Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR-T Cellular Immunotherapy Drug Market Challenges
Table 22. Global CAR-T Cellular Immunotherapy Drug Sales by Type (K Units)
Table 23. Global CAR-T Cellular Immunotherapy Drug Market Size by Type (M USD)
Table 24. Global CAR-T Cellular Immunotherapy Drug Sales (K Units) by Type (2019-2025)
Table 25. Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Type (2019-2025)
Table 26. Global CAR-T Cellular Immunotherapy Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global CAR-T Cellular Immunotherapy Drug Market Size Share by Type (2019-2025)
Table 28. Global CAR-T Cellular Immunotherapy Drug Price (USD/Unit) by Type (2019-2025)
Table 29. Global CAR-T Cellular Immunotherapy Drug Sales (K Units) by Application
Table 30. Global CAR-T Cellular Immunotherapy Drug Market Size by Application
Table 31. Global CAR-T Cellular Immunotherapy Drug Sales by Application (2019-2025) & (K Units)
Table 32. Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Application (2019-2025)
Table 33. Global CAR-T Cellular Immunotherapy Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global CAR-T Cellular Immunotherapy Drug Market Share by Application (2019-2025)
Table 35. Global CAR-T Cellular Immunotherapy Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global CAR-T Cellular Immunotherapy Drug Sales by Region (2019-2025) & (K Units)
Table 37. Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Region (2019-2025)
Table 38. North America CAR-T Cellular Immunotherapy Drug Sales by Country (2019-2025) & (K Units)
Table 39. Europe CAR-T Cellular Immunotherapy Drug Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific CAR-T Cellular Immunotherapy Drug Sales by Region (2019-2025) & (K Units)
Table 41. South America CAR-T Cellular Immunotherapy Drug Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa CAR-T Cellular Immunotherapy Drug Sales by Region (2019-2025) & (K Units)
Table 43. Novartis AG CAR-T Cellular Immunotherapy Drug Basic Information
Table 44. Novartis AG CAR-T Cellular Immunotherapy Drug Product Overview
Table 45. Novartis AG CAR-T Cellular Immunotherapy Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 46. Novartis AG Business Overview
Table 47. Novartis AG CAR-T Cellular Immunotherapy Drug SWOT Analysis
Table 48. Novartis AG Recent Developments
Table 49. Kite Pharma CAR-T Cellular Immunotherapy Drug Basic Information
Table 50. Kite Pharma CAR-T Cellular Immunotherapy Drug Product Overview
Table 51. Kite Pharma CAR-T Cellular Immunotherapy Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 52. Kite Pharma Business Overview
Table 53. Kite Pharma CAR-T Cellular Immunotherapy Drug SWOT Analysis
Table 54. Kite Pharma Recent Developments
Table 55. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Basic Information
Table 56. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product Overview
Table 57. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 58. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug SWOT Analysis
Table 59. Bristol Myers Squibb Business Overview
Table 60. Bristol Myers Squibb Recent Developments
Table 61. Fosun Pharma CAR-T Cellular Immunotherapy Drug Basic Information
Table 62. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product Overview
Table 63. Fosun Pharma CAR-T Cellular Immunotherapy Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 64. Fosun Pharma Business Overview
Table 65. Fosun Pharma Recent Developments
Table 66. Global CAR-T Cellular Immunotherapy Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global CAR-T Cellular Immunotherapy Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America CAR-T Cellular Immunotherapy Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 69. North America CAR-T Cellular Immunotherapy Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe CAR-T Cellular Immunotherapy Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe CAR-T Cellular Immunotherapy Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific CAR-T Cellular Immunotherapy Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 73. Asia Pacific CAR-T Cellular Immunotherapy Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America CAR-T Cellular Immunotherapy Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 75. South America CAR-T Cellular Immunotherapy Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa CAR-T Cellular Immunotherapy Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa CAR-T Cellular Immunotherapy Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global CAR-T Cellular Immunotherapy Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global CAR-T Cellular Immunotherapy Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global CAR-T Cellular Immunotherapy Drug Price Forecast by Type (2025-2030) & (USD/Unit)
Table 81. Global CAR-T Cellular Immunotherapy Drug Sales (K Units) Forecast by Application (2025-2030)
Table 82. Global CAR-T Cellular Immunotherapy Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of CAR-T Cellular Immunotherapy Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR-T Cellular Immunotherapy Drug Market Size (M USD), 2019-2030
Figure 5. Global CAR-T Cellular Immunotherapy Drug Market Size (M USD) (2019-2030)
Figure 6. Global CAR-T Cellular Immunotherapy Drug Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR-T Cellular Immunotherapy Drug Market Size by Country (M USD)
Figure 11. CAR-T Cellular Immunotherapy Drug Sales Share by Manufacturers in 2023
Figure 12. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Manufacturers in 2023
Figure 13. CAR-T Cellular Immunotherapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market CAR-T Cellular Immunotherapy Drug Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by CAR-T Cellular Immunotherapy Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CAR-T Cellular Immunotherapy Drug Market Share by Type
Figure 18. Sales Market Share of CAR-T Cellular Immunotherapy Drug by Type (2019-2025)
Figure 19. Sales Market Share of CAR-T Cellular Immunotherapy Drug by Type in 2023
Figure 20. Market Size Share of CAR-T Cellular Immunotherapy Drug by Type (2019-2025)
Figure 21. Market Size Market Share of CAR-T Cellular Immunotherapy Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CAR-T Cellular Immunotherapy Drug Market Share by Application
Figure 24. Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Application (2019-2025)
Figure 25. Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Application in 2023
Figure 26. Global CAR-T Cellular Immunotherapy Drug Market Share by Application (2019-2025)
Figure 27. Global CAR-T Cellular Immunotherapy Drug Market Share by Application in 2023
Figure 28. Global CAR-T Cellular Immunotherapy Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global CAR-T Cellular Immunotherapy Drug Sales Market Share by Region (2019-2025)
Figure 30. North America CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America CAR-T Cellular Immunotherapy Drug Sales Market Share by Country in 2023
Figure 32. U.S. CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada CAR-T Cellular Immunotherapy Drug Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico CAR-T Cellular Immunotherapy Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe CAR-T Cellular Immunotherapy Drug Sales Market Share by Country in 2023
Figure 37. Germany CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (K Units)
Figure 43. Asia Pacific CAR-T Cellular Immunotherapy Drug Sales Market Share by Region in 2023
Figure 44. China CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (K Units)
Figure 50. South America CAR-T Cellular Immunotherapy Drug Sales Market Share by Country in 2023
Figure 51. Brazil CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa CAR-T Cellular Immunotherapy Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa CAR-T Cellular Immunotherapy Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global CAR-T Cellular Immunotherapy Drug Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global CAR-T Cellular Immunotherapy Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global CAR-T Cellular Immunotherapy Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global CAR-T Cellular Immunotherapy Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global CAR-T Cellular Immunotherapy Drug Sales Forecast by Application (2025-2030)
Figure 66. Global CAR-T Cellular Immunotherapy Drug Market Share Forecast by Application (2025-2030)
